Sphera Funds Management’s Cellectis CLLS Stock Holding History

Sphera Funds Management’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-447,970	Closed	-$8.22M	–	94
2019 Q1	$8.22M	Hold	447,970	–	–	0.75%	25
2018 Q4	$7.46M	Hold	447,970	–	–	0.84%	29
2018 Q3	$12.6M	Buy	447,970 +96,096	+27%	+$2.76M	1.45%	13
2018 Q2	$9.96M	Buy	351,874 +12,507	+4%	+$372K	1.37%	18
2018 Q1	$10.7M	Hold	339,367	–	–	1.62%	15
2017 Q4	$9.89M	Sell	339,367 -9,369	-3%	-$255K	1.16%	18
2017 Q3	$9.92M	Buy	348,736 +144,972	+71%	+$3.75M	1.42%	14
2017 Q2	$5.26M	Buy	203,764 +44,100	+28%	+$1.05M	0.89%	28
2017 Q1	$3.83M	Buy	+159,664	New	+$3.35M	0.75%	36
2015 Q2	–	Sell	-50,000	Closed	-$1.73M	–	140
2015 Q1	$1.73M	Buy	+50,000	New	+$1.81M	0.18%	116

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sphera Funds Management's CLLS Position: Q2 2019 in Review

Sphera Funds Management sold out of Cellectis (CLLS) in Q2 2019, closing a stake of 447,970 shares — an estimated $8.22M sold.

Sphera Funds Management first reported a position in CLLS in Q1 2015 and held it in 10 quarters. The position peaked at $12.6M in Q3 2018. 70 funds tracked by Wall St. Rank hold CLLS as of Q2 2019.

Sphera Funds Management reported no remaining Cellectis position as of Q2 2019 after selling out during the quarter.
Sphera Funds Management sold 447,970 Cellectis shares in Q2 2019, an estimated $8.22M.
Sphera Funds Management first reported a position in Cellectis in Q1 2015 and held it in 10 quarters.
Sphera Funds Management's Cellectis position peaked at $12.6M in Q3 2018.
70 funds tracked by Wall St. Rank held Cellectis as of Q2 2019.

Based on Sphera Funds Management's 13F filing for Q2 2019, filed 14 Aug 2019.